Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
JP Morgan analyst Lisa Gill maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and raises the price target from $17...
Barclays analyst Andrew Mok maintains Alignment Healthcare (NASDAQ:ALHC) with a Equal-Weight and raises the price target fro...
UBS analyst Kevin Caliendo maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and raises the price target from $17 ...
Alignment Healthcare (NASDAQ:ALHC) raises FY2025 sales outlook from $3.885 billion-$3.910 billion to $3.931 billion-$3.946 bill...
Alignment Healthcare (NASDAQ:ALHC) sees Q4 sales of $995.000 million-$1.010 billion vs $978.058 million analyst estimate.
Alignment Healthcare (NASDAQ:ALHC) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of ...
Goldman Sachs analyst Scott Fidel initiates coverage on Alignment Healthcare (NASDAQ:ALHC) with a Buy rating and announces ...
